These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 226832)

  • 21. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
    Brümmer D; Evans D; Berg D; Greten H; Beisiegel U; Mann WA
    J Mol Med (Berl); 1998 Apr; 76(5):355-64. PubMed ID: 9587070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
    Jansen H; Hop W; van Tol A; Bruschke AV; Birkenhäger JC
    Atherosclerosis; 1994 May; 107(1):45-54. PubMed ID: 7945558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
    Goldberg AP; Applebaum-Bowden DM; Bierman EL; Hazzard WR; Haas LB; Sherrard DJ; Brunzell JD; Huttunen JK; Ehnholm C; Nikkila EA
    N Engl J Med; 1979 Nov; 301(20):1073-6. PubMed ID: 226883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue.
    Ekman R; Nilsson-Ehle P
    Clin Chim Acta; 1975 Aug; 63(1):29-35. PubMed ID: 170020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein lipase in adipose tissues of rats running during cold exposure.
    Deshaies Y; Arnold J; Richard D
    J Appl Physiol (1985); 1988 Aug; 65(2):549-54. PubMed ID: 3170404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
    Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
    Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
    Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
    Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein lipase regulation in the cyclophosphamide-treated rabbit: dependence on nutritional status.
    Lespine A; Azema C; Gafvels M; Manent J; Dousset N; Chap H; Perret B
    J Lipid Res; 1993 Jan; 34(1):23-36. PubMed ID: 8445340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
    Goldberg AP; Chait A; Brunzell JD
    Metabolism; 1980 Mar; 29(3):223-9. PubMed ID: 7374436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the hypolipidemic effect of estrogen in type III hyperlipoproteinemia.
    Stuyt PM; Demacker PN; van't Laar A
    Horm Metab Res; 1986 Sep; 18(9):607-10. PubMed ID: 3465673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelomatosis with type III hyperlipoproteinemia: clinical and metabolic studies.
    Cortese C; Lewis B; Miller NE; Peyman MA; Rao SN; Slavin B; Sule U; Turner PR; Utermann G; Wing AJ; Weight M; Wootton R
    N Engl J Med; 1982 Jul; 307(2):79-83. PubMed ID: 6283345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence of alcohol-induced initial changes in plasma lipoproteins (VLDL and HDL) and lipolytic enzymes in humans.
    Taskinen MR; Välimäki M; Nikkilä EA; Kuusi T; Ylikahri R
    Metabolism; 1985 Feb; 34(2):112-9. PubMed ID: 3969013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.
    Søndergaard E; Andersen IR; Sørensen LP; Gormsen LC; Nielsen S
    Scand J Med Sci Sports; 2017 May; 27(5):474-481. PubMed ID: 28207959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change of plasma lipoproteins by heparin-released lipoprotein lipase.
    Yang JY; Kim TK; Koo BS; Park BH; Park JW
    Exp Mol Med; 1999 Jun; 31(2):60-4. PubMed ID: 10410303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.